Usage methods and precautions for lung cancer drug Ripotinib

Repotrectinib (Repotrectinib), as a targeted therapy for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer, has brought new treatment hope to many patients. This drug can precisely act on tumor cells, inhibit their growth and spread, and thus help patients control their disease. However, in order to ensure that repotinib can exert its best effect and reduce potential adverse reactions, patients must strictly comply with medical instructions and pay attention to a series of usage methods and precautions when using it.

When using repotinib, patients should strictly follow the dosage recommended by their doctor. Usually, the recommended dose is 160 mg once a day, and after 14 days of continuous use, increase to 160 mg twice a day. This dosing regimen will be continued until disease progression or unacceptable toxicity occurs. It is worth noting that patients can take the drug at the same time every day regardless of whether they are eating or not, and they need to swallow the repotinib capsule whole with water. Do not open, squeeze, chew or dissolve the capsule.

If the patient misses a dose or vomits after taking the medication, there is no need to take additional doses. Simply skip the missed dose and continue at the next prescribed time. At the same time, patients should fully inform their doctors of their medical conditions before starting treatment, especially neurological problems, lung or respiratory diseases, and liver problems, so that doctors can make more accurate treatment decisions.

For female patients, Ripotinib may cause harm to the fetus, so women who are pregnant or planning to become pregnant should take a pregnancy test before use and use effective non-hormonal contraceptive measures during treatment and for two months after stopping the drug. Male patients should take effective contraceptive measures during the use of repotinib and within four months after stopping the drug to protect their partners from potential risks.

Additionally, patients should avoid drinking grapefruit juice or eating grapefruit during treatment to avoid increasing oxygen levels in the blood to harmful levels. At the same time, if the patient develops symptoms such as dizziness, blurred vision, memory loss, etc. that may affect driving or operating machinery, relevant activities should be suspended until the symptoms are relieved.

In short, as an important drug in the treatment of lung cancer, repotinib’s usage methods and precautions are crucial to ensure the therapeutic effect and patient safety. Patients must follow medical advice, pay close attention to their physical condition, and promptly communicate any discomfort or concerns with the doctor to ensure that treatment proceeds smoothly.

References:

https://www.drugs.com/augtyro.html